Furthermore, GRP activated the galactose metabolism pathway and inhibited abnormal enrichment of the steroid biosynthesis pathway, collectively ameliorating glucose metabolic disorders in female <i>db</i>/<i>db</i> mice via the "gut microbiota-PPAR signaling axis". Here, GRP is linked to glucose metabolism disease.